Panagora Asset Management Inc Global Blood Therapeutics, Inc. Transaction History

Panagora Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $1.99 Million - $4.2 Million	-61,563 Reduced 59.44%	42,001 $2.86 Million
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $182,637 - $306,224	8,190 Added 8.59%	103,564 $3.31 Million
Q1 2022 May 12, 2022	BUY	$25.68 - $35.59 $130,608 - $181,010	5,086 Added 5.63%	95,374 $3.3 Million
Q4 2021 Feb 10, 2022	BUY	$24.9 - $40.26 $2.25 Million - $3.63 Million	90,288 New	90,288 $2.64 Million
Q3 2021 Nov 10, 2021	SELL	$25.48 - $37.34 $71,089 - $104,178	-2,790 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$32.46 - $43.42 $6,524 - $8,727	-201 Reduced 6.72%	2,790 $98,000
Q1 2021 May 12, 2021	BUY	$38.94 - $50.85 $102,334 - $133,633	2,628 Added 723.97%	2,991 $122,000
Q4 2020 Feb 10, 2021	SELL	$37.65 - $63.77 $903 - $1,530	-24 Reduced 6.2%	363 $16,000
Q3 2020 Nov 13, 2020	BUY	$52.76 - $74.49 $2,638 - $3,724	50 Added 14.84%	387 $21,000
Q2 2020 Aug 12, 2020	BUY	$48.73 - $81.82 $16,422 - $27,573	337 New	337 $21,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.